Rosas-Peralta M, Galván-Oseguera H, Velásquez-Vélez T, Borrayo-Sánchez G

Idioma: Inglés [English version]
Referencias bibliográficas: 19
Paginas: s15-17
Archivo PDF: 148.67 Kb.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Campos-Nonato I, Oviedo-Solís C, Vargas-Meza J, Ramírez-Villalobos D, Medina-García C, Gómez-Álvarez E et al. Prevalencia, tratamiento y control de la hipertensión arterial en adultos mexicanos: resultados de la Ensanut 2022. Salud Publica Mex. 2023; 65 (supl 1): S169-S180.

2. Rosas-Peralta M, Palomo-Piñón S, Borrayo-Sánchez G, Madrid-Miller A, Almeida-Gutiérrez E, Galván-Oseguera H et al. Consenso de hipertensión arterial sistémica en México. Rev Med Inst Mex Seguro Soc. 2016; 54 (Suppl 1): S6-S51.

3. Morales-Villegas EC, Yarleque C, Almeida ML. Management of hypertension and dyslipidemia in Mexico: Evidence, gaps, and approach. Arch Cardiol Mex. 2023; 93 (1): 77-87.

4. Beaney T, Schutte AE, Stergiou GS, Borghi C, Burger D, Charchar F et al. May measurement month 2019: The Global blood pressure screening campaign of the International Society of Hypertension. Hypertension. 2020; 76 (2): 333-341.

5. Campos-Nonato I, Hernández-Barrera L, Flores-Coria A, Gómez-Álvarez E, Barquera S. Prevalencia, diagnóstico y control de hipertensión arterial en adultos mexicanos en condición de vulnerabilidad. Resultados de la Ensanut 100k. Salud Publica Mex. 2019; 61 (6): 888-897.

6. Mancia Chairperson G, Kreutz Co-Chair R, Brunstrom M, Burnier M, Grassi G et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). J Hypertens. 2023. doi: 10.1097/HJH.0000000000003480.

7. Organización para la Cooperación y el Desarrollo Económicos. OECD Health Statistics 2021. París: OECD; 2023. Disponible en: https://www.oecd-ilibrary.org/sites/ddcd9abf-en/index.html?itemId=/content/component/ddcd9abf-en%20%20

8. Guerra-López A. Hypertension and dyslipidemia. Cardiovasc Metab Sci. 2021; 32 (s3): s273-s276.

9. German CA, Baum SJ, Ferdinand KC, Gulati M, Polonsky TS, Toth PP et al. Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology. Am J Prev Cardiol. 2022; 12: 100432. doi: 10.1016/j.ajpc.2022.100432.

10. Gheorghe G, Toth PP, Bungau S, Behl T, Ilie M, Pantea Stoian A et al. Cardiovascular risk and statin therapy considerations in women. Diagnostics (Basel). 2020; 10 (7): 483.

11. Chapman N, Ching SM, Konradi AO, Nuyt AM, Khan T, Twumasi-Ankrah B et al. Arterial hypertension in women: State of the art and knowledge gaps. Hypertension. 2023; 80 (6): 1140-1149.

12. Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S; PURE Investigators-Writing Group. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J. 2009; 158 (1): 1-7.e1. doi: 10.1016/j.ahj.2009.04.019.

13. Chen S, Cheng W. Relationship between lipid profiles and hypertension: a cross-sectional study of 62,957 Chinese adult males. Front Public Health. 2022; 10: 895499. doi: 10.3389/fpubh.2022.895499.

14. Otsuka T, Takada H, Nishiyama Y, Kodani E, Saiki Y, Kato K et al. Dyslipidemia and the risk of developing hypertension in a working-age male population. J Am Heart Assoc. 2016; 5 (3): e003053. doi: 10.1161/JAHA.115.003053.

15. Cheng W, Zhuang J, Chen S. Dyslipidemia and the prevalence of hypertension: a cross-sectional study based on chinese adults without type 2 diabetes mellitus. Front Cardiovasc Med. 2022; 9: 938363.

16. Lara A, Rosas M, Pastelín G, Aguilar C, Attie F, Velázquez-Monroy O. Hipercolesterolemia e hipertensión arterial en México. Consolidación urbana actual con obesidad, diabetes y tabaquismo. Arch Cardiol Mex. 2004; 74 (3): 231-245.

17. Ancona-Vadillo AE. Dyslipidemia in women, a current overview based on cardiovascular risk. Cardiovasc Metab Sci. 2021; 32 (s3): s204-s208.

18. Basoglu OK, Tasbakan MS, Kayikcioglu M. Dyslipidemia prevalence in nonobese, nondiabetic patients with obstructive sleep apnea: does sex matter? J Clin Sleep Med. 2023; 19 (5): 889-898.

19. Lara EA, Meaney E, Ceballos RGM, Asbun BJ, Ocharán HME, Núñez SM et al. Factores de riesgo cardiovascular en la población femenina urbana de México. El estudio FRIMEX IIa. Med Int Mex. 2006; 22 (6): 484-492.